• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于将难溶性药物选择性递送至炎症脑区的双功能化脂质体。

Dual Functionalized Liposomes for Selective Delivery of Poorly Soluble Drugs to Inflamed Brain Regions.

作者信息

Giofrè Sabrina, Renda Antonio, Sesana Silvia, Formicola Beatrice, Vergani Barbara, Leone Biagio Eugenio, Denti Vanna, Paglia Giuseppe, Groppuso Serena, Romeo Valentina, Muzio Luca, Balboni Andrea, Menegon Andrea, Antoniou Antonia, Amenta Arianna, Passarella Daniele, Seneci Pierfausto, Pellegrino Sara, Re Francesca

机构信息

Dipartimento di Chimica, Università degli Studi di Milano, 20133 Milan, Italy.

School of Medicine and Surgery, University of Milano-Bicocca, 20854 Vedano al Lambro, Italy.

出版信息

Pharmaceutics. 2022 Nov 7;14(11):2402. doi: 10.3390/pharmaceutics14112402.

DOI:10.3390/pharmaceutics14112402
PMID:36365220
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9698607/
Abstract

Dual functionalized liposomes were developed to cross the blood−brain barrier (BBB) and to release their cargo in a pathological matrix metalloproteinase (MMP)-rich microenvironment. Liposomes were surface-functionalized with a modified peptide deriving from the receptor-binding domain of apolipoprotein E (mApoE), known to promote cargo delivery to the brain across the BBB in vitro and in vivo; and with an MMP-sensitive moiety for an MMP-triggered drug release. Different MMP-sensitive peptides were functionalized at both ends with hydrophobic stearate tails to yield MMP-sensitive lipopeptides (MSLPs), which were assembled into mApoE liposomes. The resulting bi-functional liposomes (i) displayed a < 180 nm diameter with a negative ζ-potential; (ii) were able to cross an in vitro BBB model with an endothelial permeability of 3 ± 1 × 10−5 cm/min; (iii) when exposed to functional MMP2 or 9, efficiently released an encapsulated fluorescein dye; (iv) showed high biocompatibility when tested in neuronal cultures; and (v) when loaded with glibenclamide, a drug candidate with poor aqueous solubility, reduced the release of proinflammatory cytokines from activated microglial cells.

摘要

开发了双功能化脂质体,以跨越血脑屏障(BBB),并在富含病理基质金属蛋白酶(MMP)的微环境中释放其所载药物。脂质体用源自载脂蛋白E受体结合域的修饰肽(mApoE)进行表面功能化,已知该肽在体外和体内均能促进药物通过血脑屏障输送至大脑;还用MMP敏感部分实现MMP触发的药物释放。不同的MMP敏感肽在两端用疏水性硬脂酸酯尾巴进行功能化,以产生MMP敏感脂肽(MSLP),将其组装到mApoE脂质体中。所得的双功能脂质体(i)直径<180 nm,ζ电位为负;(ii)能够穿过体外血脑屏障模型,内皮通透性为3±1×10−5 cm/min;(iii)当暴露于功能性MMP2或MMP9时,能有效释放包封的荧光素染料;(iv)在神经元培养物中测试时显示出高生物相容性;(v)当装载格列本脲(一种水溶性差的候选药物)时,可减少活化小胶质细胞中促炎细胞因子 的释放。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e421/9698607/a3298484623e/pharmaceutics-14-02402-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e421/9698607/7b6a145f243e/pharmaceutics-14-02402-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e421/9698607/5017f856499f/pharmaceutics-14-02402-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e421/9698607/c4c41cf7d168/pharmaceutics-14-02402-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e421/9698607/5e12eb09e36e/pharmaceutics-14-02402-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e421/9698607/d19337e61a98/pharmaceutics-14-02402-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e421/9698607/3a1359128e8f/pharmaceutics-14-02402-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e421/9698607/b1d9bc73c275/pharmaceutics-14-02402-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e421/9698607/2bd9a373fa50/pharmaceutics-14-02402-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e421/9698607/8629997dd5fb/pharmaceutics-14-02402-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e421/9698607/a3298484623e/pharmaceutics-14-02402-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e421/9698607/7b6a145f243e/pharmaceutics-14-02402-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e421/9698607/5017f856499f/pharmaceutics-14-02402-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e421/9698607/c4c41cf7d168/pharmaceutics-14-02402-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e421/9698607/5e12eb09e36e/pharmaceutics-14-02402-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e421/9698607/d19337e61a98/pharmaceutics-14-02402-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e421/9698607/3a1359128e8f/pharmaceutics-14-02402-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e421/9698607/b1d9bc73c275/pharmaceutics-14-02402-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e421/9698607/2bd9a373fa50/pharmaceutics-14-02402-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e421/9698607/8629997dd5fb/pharmaceutics-14-02402-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e421/9698607/a3298484623e/pharmaceutics-14-02402-g010.jpg

相似文献

1
Dual Functionalized Liposomes for Selective Delivery of Poorly Soluble Drugs to Inflamed Brain Regions.用于将难溶性药物选择性递送至炎症脑区的双功能化脂质体。
Pharmaceutics. 2022 Nov 7;14(11):2402. doi: 10.3390/pharmaceutics14112402.
2
Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect Aβ aggregation features and cross the blood-brain-barrier: implications for therapy of Alzheimer disease.双功能化磷脂酸和载脂蛋白 E 衍生肽脂质体影响 Aβ 聚集特征并穿过血脑屏障:阿尔茨海默病治疗的意义。
Nanomedicine. 2014 Oct;10(7):1583-90. doi: 10.1016/j.nano.2013.12.001. Epub 2013 Dec 10.
3
SPRi analysis of molecular interactions of mApoE-functionalized liposomes as drug delivery systems for brain diseases.表面等离子体共振分析 mApoE 功能化脂质体作为脑疾病药物传递系统的分子相互作用。
Analyst. 2023 Nov 20;148(23):6070-6077. doi: 10.1039/d3an01507f.
4
The synergistic effect of chlorotoxin-mApoE in boosting drug-loaded liposomes across the BBB.氯毒素-mApoE 的协同作用增强了载药脂质体通过血脑屏障的能力。
J Nanobiotechnology. 2019 Nov 11;17(1):115. doi: 10.1186/s12951-019-0546-3.
5
The use of liposomes functionalized with the NFL-TBS.40-63 peptide as a targeting agent to cross the in vitro blood-brain barrier and target glioblastoma cells.使用用NFL-TBS.40-63肽功能化的脂质体作为靶向剂,以穿过体外血脑屏障并靶向胶质母细胞瘤细胞。
Int J Pharm. 2023 Nov 5;646:123421. doi: 10.1016/j.ijpharm.2023.123421. Epub 2023 Sep 16.
6
Functionalized liposomes and phytosomes loading Annona muricata L. aqueous extract: Potential nanoshuttles for brain-delivery of phenolic compounds.功能化脂质体和植物甾醇体负载番荔枝 L. 水提物:酚类化合物脑内递药的潜在纳米载体。
Phytomedicine. 2018 Mar 15;42:233-244. doi: 10.1016/j.phymed.2018.03.053. Epub 2018 Mar 19.
7
Intelligent "Peptide-Gathering Mechanical Arm" Tames Wild "Trojan-Horse" Peptides for the Controlled Delivery of Cancer Nanotherapeutics.智能“肽收集机械臂”驯服野生“特洛伊木马”肽,用于癌症纳米治疗的控制释放。
ACS Appl Mater Interfaces. 2017 Dec 6;9(48):41767-41781. doi: 10.1021/acsami.7b15523. Epub 2017 Nov 21.
8
Dual effect of TAT functionalized DHAH lipid nanoparticles with neurotrophic factors in human BBB and microglia cultures.TAT 功能化 DHAH 脂质纳米粒对人 BBB 和小胶质细胞培养中神经营养因子的双重作用。
Fluids Barriers CNS. 2022 Mar 17;19(1):22. doi: 10.1186/s12987-022-00315-1.
9
Co-delivery of doxorubicin and erlotinib through liposomal nanoparticles for glioblastoma tumor regression using an in vitro brain tumor model.通过脂质体纳米粒共递送阿霉素和厄洛替尼用于体外脑肿瘤模型的脑胶质母细胞瘤肿瘤消退。
Colloids Surf B Biointerfaces. 2019 Jan 1;173:27-35. doi: 10.1016/j.colsurfb.2018.09.047. Epub 2018 Sep 21.
10
Dual functionalized liposomes for efficient co-delivery of anti-cancer chemotherapeutics for the treatment of glioblastoma.用于高效共递送抗癌化疗药物治疗脑胶质母细胞瘤的双功能化脂质体。
J Control Release. 2019 Aug 10;307:247-260. doi: 10.1016/j.jconrel.2019.06.033. Epub 2019 Jun 26.

引用本文的文献

1
Engineered Glibenclamide-Loaded Nanovectors Hamper Inflammasome Activation in an Ex Vivo Alzheimer's Disease Model-A Novel Potential Therapy for Neuroinflammation: A Pilot Study.工程化载有格列本脲的纳米载体在体外阿尔茨海默病模型中抑制炎性小体激活——一种神经炎症的新型潜在疗法:一项初步研究
Biomolecules. 2025 Jul 24;15(8):1074. doi: 10.3390/biom15081074.
2
Brain Endothelial Cells in Blood-Brain Barrier Regulation and Neurological Therapy.血脑屏障调节与神经治疗中的脑内皮细胞
Int J Mol Sci. 2025 Jun 18;26(12):5843. doi: 10.3390/ijms26125843.
3
Crossing the blood-brain barrier: nanoparticle-based strategies for neurodegenerative disease therapy.

本文引用的文献

1
Givinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics.吉维司他脂质体:对二维和三维胶质母细胞瘤模型的抗肿瘤作用及药代动力学
Cancers (Basel). 2022 Jun 16;14(12):2978. doi: 10.3390/cancers14122978.
2
Crossing the Blood-Brain Barrier: Advances in Nanoparticle Technology for Drug Delivery in Neuro-Oncology.穿越血脑屏障:神经肿瘤学中用于药物递释的纳米颗粒技术的进展。
Int J Mol Sci. 2022 Apr 9;23(8):4153. doi: 10.3390/ijms23084153.
3
Neuroinflammation, Stroke, Blood-Brain Barrier Dysfunction, and Imaging Modalities.
穿越血脑屏障:基于纳米颗粒的神经退行性疾病治疗策略
Drug Deliv Transl Res. 2025 Jun 14. doi: 10.1007/s13346-025-01887-9.
4
Transgenic zebrafish embryos to evaluate the in vivo effects of different liposome-paclitaxel nanocarrier system.转基因斑马鱼胚胎用于评估不同脂质体-紫杉醇纳米载体系统的体内效应。
Sci Rep. 2025 May 26;15(1):18358. doi: 10.1038/s41598-025-00258-1.
5
Automated fluorine-18 radiolabeling via an alkyne-azide cycloaddition reaction on a dual peptide-functionalized liposome surface for PET imaging.通过炔烃-叠氮环加成反应在双肽功能化脂质体表面进行自动化氟-18放射性标记用于正电子发射断层显像(PET)成像。
Front Pharmacol. 2025 Apr 28;16:1566257. doi: 10.3389/fphar.2025.1566257. eCollection 2025.
6
Double Peptide-Functionalized Carboxymethyl Chitosan-Coated Liposomes Loaded with Dexamethasone as a Potential Strategy for Active Targeting Drug Delivery.负载地塞米松的双肽功能化羧甲基壳聚糖包被脂质体作为主动靶向给药的潜在策略
Int J Mol Sci. 2025 Jan 22;26(3):922. doi: 10.3390/ijms26030922.
7
A novel, glutathione-activated prodrug of pimasertib loaded in liposomes for targeted cancer therapy.一种新型的负载于脂质体中的谷胱甘肽激活的匹马替尼前药,用于靶向癌症治疗。
RSC Med Chem. 2024 Oct 3;16(1):168-78. doi: 10.1039/d4md00517a.
8
Glibenclamide-Loaded Engineered Nanovectors (GNVs) Modulate Autophagy and NLRP3-Inflammasome Activation.载有格列本脲的工程化纳米载体(GNV)调节自噬和NLRP3炎性小体激活。
Pharmaceuticals (Basel). 2023 Dec 13;16(12):1725. doi: 10.3390/ph16121725.
9
Glibenclamide-Loaded Nanoparticles Reduce NLRP3 Inflammasome Activation and Modulate miR-223-3p/miR-7-1-5p Expression in THP-1 Cells.格列本脲负载纳米颗粒可降低THP-1细胞中NLRP3炎性小体的激活并调节miR-223-3p/miR-7-1-5p的表达。
Pharmaceuticals (Basel). 2023 Nov 10;16(11):1590. doi: 10.3390/ph16111590.
10
Raman Spectroscopy Characterization of Multi-Functionalized Liposomes as Drug-Delivery Systems for Neurological Disorders.用于神经疾病的多功能脂质体作为药物递送系统的拉曼光谱表征
Nanomaterials (Basel). 2023 Feb 11;13(4):699. doi: 10.3390/nano13040699.
神经炎症、中风、血脑屏障功能障碍和成像方式。
Stroke. 2022 May;53(5):1473-1486. doi: 10.1161/STROKEAHA.122.036946. Epub 2022 Apr 7.
4
A Review of Liposomes as a Drug Delivery System: Current Status of Approved Products, Regulatory Environments, and Future Perspectives.脂质体作为药物传递系统的综述:已批准产品的现状、监管环境和未来展望。
Molecules. 2022 Feb 17;27(4):1372. doi: 10.3390/molecules27041372.
5
Microglia in Neuroinflammation and Neurodegeneration: From Understanding to Therapy.神经炎症和神经退行性变中的小胶质细胞:从认识到治疗
Front Neurosci. 2021 Sep 24;15:742065. doi: 10.3389/fnins.2021.742065. eCollection 2021.
6
Radiation and adjuvant drug-loaded liposomes target glioblastoma stem cells and trigger in-situ immune response.辐射和辅助载药脂质体靶向胶质母细胞瘤干细胞并引发原位免疫反应。
Neurooncol Adv. 2021 Jun 18;3(1):vdab076. doi: 10.1093/noajnl/vdab076. eCollection 2021 Jan-Dec.
7
Stimulus-responsive liposomes for biomedical applications.用于生物医学应用的刺激响应性脂质体。
Drug Discov Today. 2021 Aug;26(8):1794-1824. doi: 10.1016/j.drudis.2021.05.010. Epub 2021 May 29.
8
Surfactant-Free Glibenclamide Nanoparticles: Formulation, Characterization and Evaluation of Interactions with Biological Barriers.无表面活性剂格列本脲纳米粒的制备、表征及与生物屏障相互作用的评价。
Pharm Res. 2021 Jun;38(6):1081-1092. doi: 10.1007/s11095-021-03056-2. Epub 2021 May 17.
9
H-Ferritin nanoparticle-mediated delivery of antibodies across a BBB in vitro model for treatment of brain malignancies.H-铁蛋白纳米颗粒介导抗体在体外血脑屏障模型中的递送用于治疗脑恶性肿瘤。
Biomater Sci. 2021 Mar 21;9(6):2032-2042. doi: 10.1039/d0bm01726d. Epub 2021 Feb 5.
10
Comprehensive analysis of liposome formulation parameters and their influence on encapsulation, stability and drug release in glibenclamide liposomes.综合分析脂质体配方参数及其对格列本脲脂质体包封率、稳定性和药物释放的影响。
Int J Pharm. 2021 Jan 5;592:120051. doi: 10.1016/j.ijpharm.2020.120051. Epub 2020 Nov 5.